NeuroMetrix Files with FDA for Pain Therapy Device

Later this year, NeuroMetrix hopes to launch a new device to treat the effects of diabetic peripheral neuropathy (DPN). They are working with the FDA to get their new product through the regulatory process. They currently have a nerve conduction testing product that is used as a diagnostic tool for DPN. READ MORE

Source: NeuroMetrix